RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells
Authors:
- Y-P LiuYLY-P Liu
- C-H LaiCLC-H Lai
- Y-S ShanYSY-S Shan
- H-C ChengHCH-C Cheng
- P-I HsuPHP-I Hsu
- C-H LeeCLC-H Lee
- Y-C LeeYLY-C Lee
- H-Y WangHWH-Y Wang
- C-H WangCWC-H Wang
- J Q ChengJCJ Q Cheng
- M HsiaoM Hsiao
- 9 January 2012
- journal article
- Published by Springer Nature in Oncogene
- Vol. 31 (39) , 4302-4316
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes.Keywords
This publication has 58 references indexed in Scilit:
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Diet and the risk of gastric cancer: review of epidemiological evidenceGastric Cancer, 2007
- RUNX3 Inhibits the Expression of Vascular Endothelial Growth Factor and Reduces the Angiogenesis, Growth, and Metastasis of Human Gastric CancerClinical Cancer Research, 2006
- The RUNX3 Tumor Suppressor Upregulates Bim in Gastric Epithelial Cells Undergoing Transforming Growth Factorβ-Induced ApoptosisMolecular and Cellular Biology, 2006
- Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancerInternational Journal of Cancer, 2005
- RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor β-Activated SMADMolecular and Cellular Biology, 2005
- Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl‐2, MDR‐1 and MRP‐1International Journal of Cancer, 2005
- Molecular basis of gastric cancer development and progressionGastric Cancer, 2004